Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2010
11/02/2010CA2407466C Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/02/2010CA2392350C Hematological assay and reagent
11/02/2010CA2341520C Energy transfer dyes
11/02/2010CA2337422C Preventing airway mucus production by administration of egf-r antagonists
11/02/2010CA2302134C Composition and methods for monitoring the binding of a1/up1 to telomeric dna sequences and telomerase rna, and to measure the effect of this binding on telomere extension and protection
11/02/2010CA2265989C Methods for in vitro determination of erythropoietin bioactivity
11/02/2010CA2253246C Purified multimerase
11/02/2010CA2198702C Detection of hypermutable nucleic acid sequence in tissue
11/01/2010CA2665302A1 Cd36 modulation and uses thereof
10/2010
10/28/2010WO2010124277A2 Materials and methods for assessing and mapping microbes and microbial biofilms on wounds
10/28/2010WO2010124269A1 Methods for diagnosis of sepsis and risk of death
10/28/2010WO2010124262A1 Methods of identification of allosteramers and uses thereof
10/28/2010WO2010124257A2 Methods and kits for determining oxygen free radical (ofr) levels in animal and human tissues as a prognostic marker for cancer and other pathophysiologies
10/28/2010WO2010124256A2 Methods and systems for identifying immunomodulatory substances
10/28/2010WO2010124240A2 Bin1 as a prognostic marker in cardiovascular disease
10/28/2010WO2010124227A2 Methods and devices for capturing circulating tumor cells
10/28/2010WO2010124226A2 Toll-like receptor-based biosensors
10/28/2010WO2010124210A2 Multiplexed biomolecule arrays made by polymer pen lithography
10/28/2010WO2010124208A1 A tracer method to estimate rates of methane generation through augmentation or biostimulation of the sub-surface
10/28/2010WO2010124157A1 Cellular assay employing detectable protein
10/28/2010WO2010124058A1 Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
10/28/2010WO2010123949A1 Methods of detecting hpv strains using synergistic antibodies
10/28/2010WO2010123892A2 Swept source optical coherence tomography (oct) method and system
10/28/2010WO2010123883A2 Photoacoustic detection of analytes in solid tissue and detection system
10/28/2010WO2010123874A1 Antibodies specific to cadherin-17
10/28/2010WO2010123813A1 Immunogenic epitopes of ngep antigen
10/28/2010WO2010123720A1 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
10/28/2010WO2010123594A2 Device for filtration of fluids there through and accompanying method
10/28/2010WO2010123577A2 Compositions and methods for evaluating cognitive deficits
10/28/2010WO2010123561A1 Antibodies specific to e6 proteins of hpv and use thereof
10/28/2010WO2010123519A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010WO2010123462A1 Vesicular system and uses thereof
10/28/2010WO2010123448A1 Method for reducing adsorption losses on metal oxide surfaces
10/28/2010WO2010123283A9 Fluorescently marked cohesin marker, and a cellulosome-forming-enzyme detection method employing the same
10/28/2010WO2010123283A2 Fluorescently marked cohesin marker, and a cellulosome-forming-enzyme detection method employing the same
10/28/2010WO2010123216A2 Method for using cfh or apoh as a biochemical marker for diagnosis of acute myeloid leukemia
10/28/2010WO2010123159A1 Marker for diagnosing lung cancer and colorectal cancer containing glutaredoxin 3 as active ingredient and kit for diagnosing lung cancer and colorectal cancer using the same
10/28/2010WO2010123124A1 Recurrence and prognosis factor for solid cancer, and use thereof for clinical purposes
10/28/2010WO2010123119A1 Therapeutic agent and screening method for inflammatory bowel disease
10/28/2010WO2010123085A1 Trapping compounds and method for identifying reactive metabolites
10/28/2010WO2010123083A1 Polypeptide derived from mouse hepatitis virus and/or polypeptide derived from sendai virus, test kit for infection by mouse hepatitis virus and/or sendai virus using the polypeptide, and method for detecting infection by mouse hepatitis virus and/or sendai virus
10/28/2010WO2010123080A1 Method for producing soluble sr-a protein and evaluation method using same
10/28/2010WO2010123073A1 Assay method using plasmon excitation sensor comprising stimulus-responsive polymer
10/28/2010WO2010123065A1 Cancer antigen helper peptide
10/28/2010WO2010123039A1 Composition for immobilizing biological material
10/28/2010WO2010123008A1 Method for evaluating skin barrier function recovery-accelerator using work function as indication
10/28/2010WO2010122990A1 Tube for measuring bio-related substance and quantifying system
10/28/2010WO2010122946A1 Periodontal disease markers
10/28/2010WO2010122846A1 Cocktail antibody for determining histological type of carcinoma, determination kit and determination method
10/28/2010WO2010122413A1 Detecting gas compounds for downhole fluid analysis using microfluidics and reagent with optical signature
10/28/2010WO2010122392A1 Single-step sample processing device
10/28/2010WO2010122383A1 Pigment orientation estimating method
10/28/2010WO2010122293A1 Lipid bilayer sensor array
10/28/2010WO2010122270A1 System for detecting hybridization complexes of probes with specific ligands and uses thereof
10/28/2010WO2010122234A1 Antibodies directed to tra antigens, and methods of production, screening and analysis of said antibodies, as well as methods of analysis of stem cells and cancer cell
10/28/2010WO2010122232A1 An antibody-glycan complex targeting the disialyl core ii and sialyl lewis x structures, and uses thereof involving analysis of stem cells or cancer cells
10/28/2010WO2010122231A1 Methods for determining maternal health risks
10/28/2010WO2010122194A1 Method for obtaining metallic nanoparticles
10/28/2010WO2010122181A1 Oligomeric proteins and the uses thereof
10/28/2010WO2010122176A1 A method to identify glycosaminoglycan (gag) binding sites in proteins
10/28/2010WO2010122160A1 Method for diagnosing a hemoglobin-related disorder
10/28/2010WO2010122158A1 A lateral flow assay device for coagulation monitoring and method thereof
10/28/2010WO2010121909A1 Method and apparatus for optical examination of liquids
10/28/2010WO2010121834A2 Irak kinase family as novel target and biomarker for alzheimer
10/28/2010WO2010121714A1 Complexes between phospholipids and protein vimentin, and in vitro methods for the detection of antibodies against these complexes
10/28/2010WO2010121370A1 Prognostic gene expression signature for squamous cell carcinoma of the lung
10/28/2010WO2010121335A1 Method for isolating exosomes from biological solutions using iron oxide nanoparticles
10/28/2010WO2010121315A1 Method and apparatus for isolating a target bioentity from a biological sample
10/28/2010WO2010121294A1 Methods for obtaining fetal genetic material
10/28/2010WO2010121288A1 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR α-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR α-CHAIN
10/28/2010WO2010099342A3 Methods of detecting lung cancer
10/28/2010WO2010090848A3 Apparatus and method to characterize blood and red blood cells via erythrocyte membrane fragility quantification
10/28/2010WO2010090450A3 Tracing and detection method of oil product by enzyme-linked immunosorbent assay technology
10/28/2010WO2010085673A3 Lighting design of high quality biomedical devices
10/28/2010WO2010083252A3 Ratio based biomarkers and methods of use thereof
10/28/2010WO2010080765A3 High-throughput production of ingestible event markers
10/28/2010WO2010078514A3 Quantification of non-reducing end glycan residual compounds
10/28/2010WO2010078465A3 Capillary flow solid phase assay
10/28/2010WO2010077870A3 Stable compositions comprising chromogenic compounds and methods of use
10/28/2010WO2010077473A3 Monoclonal antibodies that react with the capsule of bacillus anthracis
10/28/2010WO2010077366A3 Exponential isothermal self-sustained replication of an rna enzyme
10/28/2010WO2010075568A3 Biological analysis systems, devices and methods
10/28/2010WO2010070590A8 Integrated methods for corrosivity, ageing and fingerprinting determination, as well as diagnosis, decontamination, depolarisation and detoxification of oils.
10/28/2010WO2010034514A3 Cfhr1 as a c5 convertase inhibitor for the treatment of autoimmune diseases
10/28/2010WO2010027499A3 Methods, compositions and vaccines relating to neisseria meningitidis antibodies
10/28/2010WO2010018378A8 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
10/28/2010WO2009149615A8 A method of quickly determining human abo/rh/mn blood type and a test kit thereof
10/28/2010WO2007028030A3 Oncogenic regulatory rnas for diagnostics and therapeutics
10/28/2010WO2006053328A3 Biomarkers for screening, predicting, and monitoring prostate disease
10/28/2010US20100275284 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
10/28/2010US20100275280 Method for identifying, expanding and removing adult stem cells and cancer stem cells
10/28/2010US20100275276 Zebrafish model for assessing gastrointestinal motility
10/28/2010US20100275275 HADHs as Modifiers of the p21 Pathway and Methods of Use
10/28/2010US20100275274 Mouse model for depression, schizophrenia and alzheimer's disease
10/28/2010US20100274499 Nucleic acid amplification determining method and nucleic acid amplification determining device
10/28/2010US20100274498 Information providing system and analyzer
10/28/2010US20100274497 Closed Loop Blood Glucose Control Algorithm Analysis
10/28/2010US20100274494 Bioequivalence evaluation method of evaluating bioequivalence of a generic drug to the corresponding original drug
10/28/2010US20100274110 Optical determination of ph and glucose
10/28/2010US20100274077 Method for surface inclusions detection in nitinol which are primary corrosion and fatigue initiation sites and indicators of overall quality of nitinol material
1 ... 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 ... 3937